Ads
related to: glaxosmithkline
Search results
GSK faces whistleblower lawsuit over Zantac cancer risk
WSAU Wausau· 6 days agoBy Jonathan Stempel (Reuters) - GSK has been sued by an independent Connecticut laboratory that...
Updates in Parkinson's, ICH, Migraine, Muscular Dystrophy
Medscape· 4 days agoProf Christoph Diener discusses his picks for updates in neurology that were published in April...
GSK Discovered Vaccine That Protects Against RSV, Paul Singer
Dealbreaker· 5 days agoPaul Singer may or may not have become a nicer person over the last few years, but that doesn’t mean...
23andMe Fiscal Q4 Revenues Drop 31 Percent as Research Services, Genetic Test Kit Sales Shrink
GenomeWeb News· 3 days agoThe firm attributed the decrease largely to lower research services revenue due to ending a collaboration with GlaxoSmithKline, as well as lower consumer services revenue ...
Durham biotech, Eli Lilly ink billion-dollar deal aimed at cancer treatments - Triangle Business...
The Business Journals· 4 days agoA biotechnology firm with operations in Durham is working on a major deal with with Eli Lilly and...
Infinant Health Appoints New Team Members to assist with Drug Development
WPRI Providence· 5 days agoInfinant Health, a privately-held company focused on changing the trajectory of human health by supporting the development and restoration of the immune system via the gut microbiome, announces ...
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk
Reuters· 6 days ago, opens new tab has been sued by an independent Connecticut laboratory that accused the drugmaker of...
Explainer-What to know about bird flu in dairy cows and the risk to humans By Reuters
Investing.com· 4 days agoCHICAGO (Reuters) -A second human case of bird flu was confirmed in a dairy worker in Michigan, U.S....
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk By Reuters
Investing.com· 6 days agoIn a whistleblower complaint filed on Monday, Valisure said GSK violated the federal False Claims...
GSK says late-stage trials of potential blockbuster asthma drug met their goals
Morningstar· 6 days agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than GBP3 billion ($3.8 billion) met their goals. GSK (GSK) (UK:GSK) said both trials of depemokimab ...
Ad
related to: glaxosmithklineopvee.com has been visited by 10K+ users in the past month